Abstract:Background: Glaucoma, the leading cause of irreversible blindness worldwide, is a type of retinal disease characterized by the selective death of retinal ganglion cells (RGCs). However, the pathogenesis of glaucoma has not been fully elucidated. Transient receptor potential vanilloid 4 (TRPV4) is a pressure-sensitive and calcium-permeable cation channel. TRPV4 is widely distributed in the retina and its sustained activation leads to RGC death; indicating that TRPV4 may be a possible target for glaucoma treatment. Here, we investigated the effects of TRPV4 on RGC apoptosis in a rat model of chronic ocular hypertension (COH), then examined the mechanism underlying these effects. Methods: The COH model was established by injection of micro-magnetic beads into the anterior chamber of adult male rats. The expression levels of TRPV4, glial fibrillary acidic protein, and inflammatory factors were assessed by immunohistochemistry and immunoblotting. RGC apoptosis and visual dysfunction were evaluated by TUNEL assay and photopic negative response. Functional expression of TRPV4 was examined by electrophysiology and calcium imaging. Real-time polymerase chain reaction and immunoblotting were employed to investigate the molecular mechanism underlying the effects of TRPV4 on tumor necrosis factor-α (TNF-α) release. Results: We found that TRPV4 played an essential role in glaucoma, such that high levels of TRPV4 expression were associated with elevated intraocular pressure. Furthermore, TRPV4 activation was involved in glaucoma-induced RGC apoptosis and RGC-related reductions in visual function. Mechanistic investigation demonstrated that TRPV4 activation led to enhanced Müller cell gliosis and TNF-α release via the JAK2/STAT3/NF-kB pathway, while TRPV4 inhibition could reverse these effects. Finally, TRPV4 activation could lead to elevated expression of TNF receptor 1 in RGCs, while inhibition of TNF-α could reduce TRPV4-mediated RGC apoptosis. Conclusions: TRPV4 activation induces Müller cell gliosis and TNF-α elevation via the JAK2/STAT3/NF-κB pathway, which may exacerbate RGC apoptosis in glaucoma; these results suggest that TRPV4 can serve as a therapeutic target in glaucoma treatment.

EphA4/ephrinA3 Reverse Signaling Induced Müller Cell Gliosis and Production of Pro-Inflammatory Cytokines in Experimental Glaucoma.

Activated ephrinA3/EphA4 forward signaling induces retinal ganglion cell apoptosis in experimental glaucoma

EphA4/ephrinA3 reverse signaling mediated downregulation of glutamate transporter GLAST in Müller cells in an experimental glaucoma model

EphrinB/EphB Forward Signaling in Müller Cells Causes Apoptosis of Retinal Ganglion Cells by Increasing Tumor Necrosis Factor Alpha Production in Rat Experimental Glaucomatous Model

Involvement of Mglur I in EphB/ephrinB Reverse Signaling Activation Induced Retinal Ganglion Cell Apoptosis in a Rat Chronic Hypertension Model

Signaling mechanisms of growth hormone-releasing hormone receptor in LPS-induced acute ocular inflammation.

GluA2 Trafficking is Involved in Apoptosis of Retinal Ganglion Cells Induced by Activation of EphB/EphrinB Reverse Signaling in a Rat Chronic Ocular Hypertension Model

Interplay between Müller cells and microglia aggravates retinal inflammatory response in experimental glaucoma

The Effect of A2AReceptor Antagonist on Microglial Activation in Experimental Glaucoma

Group I mGluR-mediated inhibition of Kir channels contributes to retinal Müller cell gliosis in a rat chronic ocular hypertension model.

Involvement of the MEK-ERK/p38-CREB/c-fos Signaling Pathway in Kir Channel Inhibition-Induced Rat Retinal Müller Cell Gliosis.

Effect of Adenosine and Adenosine Receptor Antagonist on Müller Cell Potassium Channel in Rat Chronic Ocular Hypertension Models

Differences in Müller's glia between the central and peripheral retina and its effect in glaucoma

MicroRNA-93/STAT3 signalling pathway mediates retinal microglial activation and protects retinal ganglion cells in an acute ocular hypertension model

TRPV4-induced Müller cell gliosis and TNF-α elevation-mediated retinal ganglion cell apoptosis in glaucomatous rats via JAK2/STAT3/NF-κB pathway

Dopamine D1 Receptor‐mediated Upregulation of BKCa Currents Modifies Müller Cell Gliosis in a Rat Chronic Ocular Hypertension Model

Cytokine Profiling in Aqueous Humor of Glaucoma Patients and in Retinas from an Ex Vivo Glaucoma Animal Model

Fractalkine receptor regulates microglial neurotoxicity in an experimental mouse glaucoma model.

Neurobiology of Disease GluA 2 Trafficking Is Involved in Apoptosis of Retinal Ganglion Cells Induced by Activation of EphB / EphrinB Reverse Signaling in a Rat Chronic Ocular Hypertension Model

Neuroprotection of the P2X7 receptor antagonist A740003 on retinal ganglion cells in experimental glaucoma

Therapeutic Retrobulbar Inhibition of STAT3 Protects Ischemic Retina Ganglion Cells